Related Experiment Video
Updated: Jan 22, 2026

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
Published on: April 13, 2018
NME4 may enhance non‑small cell lung cancer progression by overcoming cell cycle arrest and promoting cellular
Wenqian Wang1, Ming Dong2, Jie Cui1
1Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China.
Abstract:
Nucleoside diphosphate kinase 4 (NME4) is abnormally expressed in a variety of cancer types. However, the function of the NME4 gene in non‑small cell lung cancer (NSCLC) remains to be elucidated. In order to investigate the role of NME4 in NSCLC, the present study detected the expression of the NME4 gene in the Cancer Genome Atlas database, and in BEAS‑2B, NCI‑H1299 and A549 cell lines. NME4 was significantly overexpressed in NSCLC tissues and NSCLC cell lines. Furthermore, lentivirus‑mediated knockdown vector infection, cell proliferation, cell cycle, apoptosis, colony formation and MTT assays were conducted to explore the effect of NME4 on NSCLC in vitro. After knockdown of NME4 with short hairpin RNA, the cell cycle was arrest at the G1 phase, and proliferation and colony formation were inhibited in the NCI‑H1299 and A549 cell lines. The present results suggested that NME4 may serve as a novel tumor promoter, capable of enhancing NSCLC progression by overcoming cell cycle arrest and promoting proliferation.
Insights
Nucleoside diphosphate kinase 4 (NME4) is overexpressed in non-small cell lung cancer (NSCLC). Knocking down NME4 inhibits NSCLC cell proliferation and progression by arresting the cell cycle.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Nucleoside diphosphate kinase 4 (NME4) exhibits abnormal expression across various cancer types.
- The specific role of the NME4 gene in non-small cell lung cancer (NSCLC) pathogenesis requires further investigation.
Purpose of the Study:
- To elucidate the function of NME4 in non-small cell lung cancer (NSCLC).
- To determine the expression levels of NME4 in NSCLC tissues and cell lines.
- To assess the impact of NME4 on NSCLC progression in vitro.
Main Methods:
- Gene expression analysis using The Cancer Genome Atlas (TCGA) database and NSCLC cell lines (BEAS-2B, NCI-H1299, A549).
- In vitro functional assays including lentivirus-mediated NME4 knockdown using short hairpin RNA (shRNA).
- Assessment of cell proliferation, cell cycle distribution, apoptosis, colony formation, and MTT assays.
Main Results:
- NME4 was found to be significantly overexpressed in both NSCLC tissues and cell lines.
- Knockdown of NME4 expression led to cell cycle arrest at the G1 phase.
- Inhibition of NME4 significantly suppressed cell proliferation and colony formation in NCI-H1299 and A549 cells.
Conclusions:
- NME4 acts as a tumor promoter in NSCLC.
- NME4 enhances NSCLC progression by promoting cell proliferation and overcoming cell cycle arrest.
- NME4 represents a potential novel therapeutic target for NSCLC treatment.
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
What is the Cell Cycle?
What is the Cell Cycle?
Cells Coordinate Growth and Proliferation
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
The Cell Cycle Control System

